News
Corvus' soquelitinib shows promise in oncology & autoimmune fields, with Phase 3 PTCL data as a key catalyst. Click here to ...
Nigeria’s leading fully integrated edible oil business, has announced its unaudited financial results for the first quarter ended 31 March 2025, achieving record-breaking profitability and continued ...
“ATI-2138 potently and selectively blocks both ITK and JAK3. Through this mechanism, ATI-2138 has been shown in preclinical studies to effectively inhibit Th1, Th2 and Th17 cell activity, which are ...
“ATI-2138 potently and selectively blocks both ITK and JAK3. Through this mechanism, ATI-2138 has been shown in preclinical studies to effectively inhibit Th1, Th2 and Th17 cell ...
FBN Holdings Plc, a financial holding company, has announced a change in its brand name to First HoldCo Plc, FirstHoldco. A statement from the firm on Tuesday stated that the rebranding would be ...
Levels of BTK, ITK, phospholipase C-γ (PLC-γ)1 and (PLC-γ)2 in human blood were assessed by qRT-PCR. RNA in human blood was extracted from PAXgene tubes using the Paxgene Blood RNA kit (Becton ...
The council was established when Bill C-29 became law on Tuesday. Obed said beyond ITK's one appointee to the council, the legislation has 'no other considerations' for bringing in more Inuit.
“Corvus is leading the development of ITK inhibition as a platform opportunity across oncology and immune diseases. The addition of Jeff as chief business officer strengthens our ability to maximize ...
For further information please contact FTSE Russell Client Services at [email protected] or call: 1st Feb 2023 8:00 am RNS Cancellation - Micro Focus International plc 31st Jan 2023 3:25 pm BUS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results